(VIANEWS) – Halozyme Therapeutics (HALO), ACM Research (ACMR), FirstCash (FCFS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Halozyme Therapeutics (HALO)
19.8% sales growth and 261.68% return on equity
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.41.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 18.83. Meaning, the purchaser of the share is investing $18.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 261.68%.
Yearly Top and Bottom Value
Halozyme Therapeutics’s stock is valued at $45.39 at 20:22 EST, below its 52-week high of $46.16 and way higher than its 52-week low of $31.86.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1.4% and 36%, respectively.
Volume
Today’s last reported volume for Halozyme Therapeutics is 1037270 which is 0.36% above its average volume of 1033540.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 862.99M for the twelve trailing months.
2. ACM Research (ACMR)
15.7% sales growth and 12.26% return on equity
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Earnings Per Share
As for profitability, ACM Research has a trailing twelve months EPS of $1.31.
PE Ratio
ACM Research has a trailing twelve months price to earnings ratio of 18.02. Meaning, the purchaser of the share is investing $18.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.26%.
Yearly Top and Bottom Value
ACM Research’s stock is valued at $23.60 at 20:22 EST, way under its 52-week high of $34.40 and way above its 52-week low of $9.18.
3. FirstCash (FCFS)
9.3% sales growth and 11.91% return on equity
FirstCash Holdings, Inc, together with its subsidiaries, operates retail pawn stores in the United States, Mexico, and rest of Latin America. Its pawn stores lend money on the collateral of pledged personal property, including jewelry, electronics, tools, appliances, sporting goods, and musical instruments; and retails merchandise acquired through collateral forfeitures on forfeited pawn loans and over-the-counter purchases of merchandise directly from customers. The company is also involved in melting scrap jewelry, as well as sells gold, silver, and diamonds in commodity markets. As of December 31, 2021, it operated 1,081 stores in the United States and the District of Columbia; 1,656 stores in Mexico; 60 stores in Guatemala; 13 stores in El Salvador; and 15 stores in Colombia. The company was incorporated in 1988 and is headquartered in Fort Worth, Texas.
Earnings Per Share
As for profitability, FirstCash has a trailing twelve months EPS of $5.13.
PE Ratio
FirstCash has a trailing twelve months price to earnings ratio of 22.56. Meaning, the purchaser of the share is investing $22.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.91%.
Yearly Top and Bottom Value
FirstCash’s stock is valued at $115.72 at 20:22 EST, way under its 52-week high of $133.64 and way higher than its 52-week low of $88.05.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 14, 2024, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 1.21%.
Moving Average
FirstCash’s value is below its 50-day moving average of $122.00 and above its 200-day moving average of $109.95.
4. Southwest Airlines (LUV)
6.8% sales growth and 3.84% return on equity
Southwest Airlines Co. operates as a passenger airline company that provides scheduled air transportation services in the United States and near-international markets. As of December 31, 2023, the company operated a total fleet of 817 Boeing 737 aircraft; and served 121 destinations in 42 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as ten near-international countries, including Mexico, Jamaica, the Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. It also provides inflight entertainment and connectivity services on Wi-Fi enabled aircraft; and Rapid Rewards loyalty program that enables program members to earn points for dollars spent on Southwest base fares. In addition, the company offers a suite of digital platforms to support customers' travel needs, including websites and apps; and SWABIZ, an online booking tool. Further, it provides ancillary services, such as Southwest's EarlyBird Check-In, upgraded boarding, and transportation of pets and unaccompanied minors. Southwest Airlines Co. was incorporated in 1967 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Southwest Airlines has a trailing twelve months EPS of $0.76.
PE Ratio
Southwest Airlines has a trailing twelve months price to earnings ratio of 36.24. Meaning, the purchaser of the share is investing $36.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 26.71B for the twelve trailing months.
5. Automatic Data Processing (ADP)
5.9% sales growth and 88.92% return on equity
Automatic Data Processing, Inc. provides cloud-based human capital management solutions worldwide. It operates in two segments, Employer Services and Professional Employer Organization (PEO). The Employer Services segment offers strategic, cloud-based platforms, and human resources (HR) outsourcing solutions. Its offerings include payroll services, benefits administration, talent management, HR management, workforce management, insurance, retirement, and compliance services, as well as integrated HCM solutions. The PEO Services segment provides HR outsourcing solution to businesses through a co-employment model. This segment offers employee benefits, protection and compliance, talent engagement, expertise, comprehensive outsourcing, and recruitment process outsourcing services. Automatic Data Processing, Inc. was founded in 1949 and is headquartered in Roseland, New Jersey.
Earnings Per Share
As for profitability, Automatic Data Processing has a trailing twelve months EPS of $8.58.
PE Ratio
Automatic Data Processing has a trailing twelve months price to earnings ratio of 28.42. Meaning, the purchaser of the share is investing $28.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 88.92%.
Yearly Top and Bottom Value
Automatic Data Processing’s stock is valued at $243.85 at 20:22 EST, below its 52-week high of $256.84 and way higher than its 52-week low of $205.53.
6. Northrim BanCorp (NRIM)
5.1% sales growth and 12.4% return on equity
Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement accounts, money market deposit accounts, and certificates of deposit. It also provides family residential mortgages; commercial loans, such as secured and unsecured loans for working capital and expansion; commercial real estate loans; construction loans for commercial real estate projects, and land development and residential subdivision construction loans; and loans for automobiles, recreational vehicles, boats, and other consumer purchases, as well as home equity and commercial credit lines, and factoring services. In addition, the company offers other services that include consumer online banking, mobile app and mobile deposit, mobile Web and text banking, business online banking, personal finance, online documents, consumer and business debit cards, home equity advantage access cards, and telebanking and automated teller services. Further, it provides personalized checks, overdraft protection from savings accounts, commercial drive-up banking, automatic transfers and payments, people pay, external and wire transfers, bill pay, direct payroll deposits, electronic tax payments, automated clearing house origination and receipt, remote deposit capture, and account reconciliation and positive pay services, as well as merchant and cash management programs, annuity products, and long term investment portfolios. As of December 31, 2020, the company operated 16 branches in Anchorage, the Matanuska-Susitna Valley, Juneau, Fairbanks, Ketchikan, Sitka, and Kenai Peninsula. Northrim BanCorp, Inc. was founded in 1990 and is headquartered in Anchorage, Alaska.
Earnings Per Share
As for profitability, Northrim BanCorp has a trailing twelve months EPS of $5.13.
PE Ratio
Northrim BanCorp has a trailing twelve months price to earnings ratio of 10.96. Meaning, the purchaser of the share is investing $10.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.4%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 33.7% and 6.1%, respectively.
Volume
Today’s last reported volume for Northrim BanCorp is 10696 which is 0.75% below its average volume of 10777.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 130.35M for the twelve trailing months.
